Search research articles
Contact Us
Filters
Showing results (131-140 of 245) with videos related to
Page
of 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma
Ryan D Cassaday, Oliver W Press, John M Pagel, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies
Eneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
British Journal of Haematology
|
November 17, 2015
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS
Raya Mawad, Pamela S Becker, Paul Hendrie, et al.
Journal of Clinical and Translational Science
|
July 16, 2021
Evaluation of the academic achievements of clinician health services research scientists involved in "pre-K" career development award programs
Erin F Barreto, Rozalina G McCoy, Joseph J Larson, et al.
Blood
|
July 13, 2013
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
Roland B Walter, Sarah A Buckley, John M Pagel, et al.
Bone Marrow Transplantation
|
October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma
R N Pham, T A Gooley, G E Keeney, et al.
Bone Marrow Transplantation
|
May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
D J Green, W I Bensinger, L A Holmberg, et al.
British Journal of Haematology
|
April 10, 2015
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age
Sarah A Buckley, Raya Mawad, Ted A Gooley, et al.
British Journal of Haematology
|
June 17, 2020
Pembrolizumab in relapsed or refractory Richter syndrome
Philippe Armand, Niels Murawski, Daniel Molin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 4, 2011
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation
Ron Ram, Ted A Gooley, David G Maloney, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 245) with videos related to
Sort By:
Page
of 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma
Ryan D Cassaday, Oliver W Press, John M Pagel, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies
Eneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
British Journal of Haematology
|
November 17, 2015
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS
Raya Mawad, Pamela S Becker, Paul Hendrie, et al.
Journal of Clinical and Translational Science
|
July 16, 2021
Evaluation of the academic achievements of clinician health services research scientists involved in "pre-K" career development award programs
Erin F Barreto, Rozalina G McCoy, Joseph J Larson, et al.
Blood
|
July 13, 2013
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
Roland B Walter, Sarah A Buckley, John M Pagel, et al.
Bone Marrow Transplantation
|
October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma
R N Pham, T A Gooley, G E Keeney, et al.
Bone Marrow Transplantation
|
May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
D J Green, W I Bensinger, L A Holmberg, et al.
British Journal of Haematology
|
April 10, 2015
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age
Sarah A Buckley, Raya Mawad, Ted A Gooley, et al.
British Journal of Haematology
|
June 17, 2020
Pembrolizumab in relapsed or refractory Richter syndrome
Philippe Armand, Niels Murawski, Daniel Molin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 4, 2011
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation
Ron Ram, Ted A Gooley, David G Maloney, et al.
Page
of 25